Literature DB >> 2175404

Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons.

K M Kelly1, R A Gross, R L Macdonald.   

Abstract

Valproic acid (VPA) is an antiepileptic drug used in the treatment of a wide variety of human seizures including generalized absence (GA) (petit mal) seizures. The mechanism of action of VPA in controlling GA seizures is not known. We tested the effects of VPA on the Ca2+ current components of acutely dissociated rat nodose ganglion neurons. VPA reduced the low-threshold (T) Ca2+ current at clinically relevant concentrations but had no effect on the high-threshold (N and L) current components. The effect on T current was concentration-dependent and most apparent at peak current. There was little effect seen on late current. VPA did not affect the rate or voltage-dependency of T current activation. The selective reduction of T current may be a means by which VPA is effective in controlling GA seizures.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175404     DOI: 10.1016/0304-3940(90)90416-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Valproate efficacy in absence seizures is hard to beat: lamotrigine comes close.

Authors:  Bassel W Abou-Khalil
Journal:  Epilepsy Curr       Date:  2005 Mar-Apr       Impact factor: 7.500

Review 2.  Antiepileptic drugs and mechanisms of epileptogenesis. A review.

Authors:  R Mutani; R Cantello; M Gianelli; C Civardi
Journal:  Ital J Neurol Sci       Date:  1995-05

Review 3.  Molecular characterization of a novel family of low voltage-activated, T-type, calcium channels.

Authors:  E Perez-Reyes
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

4.  Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.

Authors:  Michele L Ulrich; Susan Rotzinger; Sheila J Asghar; Paul Jurasz; Veronique A Tanay; Susan M J Dunn; Marek Radomski; Andy Greenshaw; Peter H Silverstone
Journal:  J Psychiatry Neurosci       Date:  2003-03       Impact factor: 6.186

5.  Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7.

Authors:  G Sansig; T J Bushell; V R Clarke; A Rozov; N Burnashev; C Portet; F Gasparini; M Schmutz; K Klebs; R Shigemoto; P J Flor; R Kuhn; T Knoepfel; M Schroeder; D R Hampson; V J Collett; C Zhang; R M Duvoisin; G L Collingridge; H van Der Putten
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

6.  Reversal of pentylenetetrazole-induced seizure activity in mice by nickel chloride.

Authors:  Ashish K Rehni; Nirmal Singh
Journal:  Indian J Pharmacol       Date:  2009-02       Impact factor: 1.200

Review 7.  CNS adverse events associated with antiepileptic drugs.

Authors:  Gina M Kennedy; Samden D Lhatoo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 8.  Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.

Authors:  W Löscher
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

Review 9.  Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

Authors:  Wolfgang Löscher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

10.  Knock-out mice reveal a critical antiepileptic role for neuropeptide Y.

Authors:  S C Baraban; G Hollopeter; J C Erickson; P A Schwartzkroin; R D Palmiter
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.